Mobile Menu

Search Results

Search results for: Cancer

Molecular diagnostics and the NHSE Long Term Plan for Cancer

Peter Johnson, National Clinical Director for Cancer, NHS England

Translating germline cancer genomics into precision prevention of cancer

Clare Turnbull, Professor of Translational Cancer Genetics, Institute of Cancer Research

Drugging the cancer genome: progress, opportunities and challenges in personalised medicine

Paul Workman, Professor of Pharmacology and Therapeutics, Institute of Cancer Research

Do Some Smokers Develop Genetic Defences Against Lung Cancer?

Written by Charlotte Harrison, Science Writer  Cigarette smoking is the leading cause of lung cancer, but only a minority of […]

A New Role for Glycolysis in Cancer Cells – Protecting Cells from Damage

Written by Charlotte Harrison, Science Writer A recent study in Nature Communications shows that not all cancer cells within a […]

Resolving tissue heterogeneity in bone, kidney and liver cancer using in situ spatial transcriptomics

The winners of the 2021 Spatial Biology EACR & NanoString Grant program, in collaboration with Illumina, will present cancer research […]

The Power of the Degradome in Cancer Therapy 

The proteasome is a large protein complex responsible for degradation of intracellular proteins and is crucial for maintaining homeostasis of […]

Impact of Next-Generation Sequencing for Lung Cancer Patients in East Asia

Written by Sharmin Begum, science writer  Next-Generation Sequencing (NGS) strategies were compared in patients with metastatic non-small cell lung cancer […]

Spinning a Yarn with the p53 Cancer Protein

Written by Charlotte Harrison, science writer  The tumour suppressor protein p53 is a key controller of cell proliferation. Mutations that […]

Clinical and Genomic Profiles of Black Patients with Prostate Cancer

Written by Sharmin Begum, science writer  Black patients who were diagnosed with metastatic hormone-sensitive prostate cancer (mHSPC), have been analysed […]